Granted… we need funding to continue our trials
Post# of 148187
The 200 million additional share will hopefully fund the huge purchase of Leronlimab from Samsung and more. We need inventory to start sales world wide. Of coarse we won’t spend the whole 200 million on Leronlimab but it will be a substantial amount with a ongoing agreement for much more.
We might also have to agree to make a nice additional down payment for our spot in line for more manufacturing. Ideally we would like our sales going forward to achieve these purchases but if you want to ramp up sales fast then this would be the most likely plan and use a good share of 200 million shares for both manufacturing and future manufacturing. Of coarse conservatively spent by Nader because we know he doesn’t like dilution. We love him for that.
Either way I can approve of this type of dilution when the big picture is massive sales world wide. Some times you just have to say WTF and throw it all in the pot and go for it all. After our first covid EUA approval this would be the right time and is a great business plan. One that makes us lots of money…
This is heads above what we were told by the 13d baggers presentation to us by the activist group. They are so out of touch on what is really happening. How can anyone not see their lack of future direction. Maybe we should follow the blind group… I don’t think so!
#gocurrentmanagement